Over Rs 656 Dividend Payout: This Leading Multinational Pharma Company Announces Its Highest-Ever Dividend; Check Record Date

On Thursday, Indian equity benchmarks traded higher, with the benchmark Nifty 50 index gaining 36.30 points, or 0.15 per cent, to 24,122.00. Amid the positive market sentiment, Abbott India share price traded at Rs 26,125, up Rs 170 or 0.65 per cent from the previous close. The company currently commands a market capitalisation of Rs 55,526 crore.

Abbott India Announces Highest-Ever Dividend

Abbott India has recommended a final dividend of Rs 525 per equity share and a special dividend of Rs 131 per equity share for FY26, taking the total dividend payout to Rs 656 per share, the highest in the company's history. The dividend is subject to shareholder approval at the upcoming Annual General Meeting scheduled for August 13, 2026. If approved, the dividend will be paid on or after August 18, 2026, to shareholders on record as of July 24, 2026.

The company currently offers a dividend yield of approximately 2.01 per cent, making it one of the notable dividend-paying stocks in the pharmaceutical sector. Over the past four years, Abbott India has consistently rewarded shareholders through both regular and special dividends.

Abbott India's Dividend Track Record

Abbott India has maintained a strong dividend payout history and has consistently rewarded shareholders through both final and special dividends.

Shareholding Pattern

Foreign Institutional Investors (FIIs) increased their stake in Abbott India from 0.19 per cent in Q3FY26 to 0.27 per cent in Q4FY26, reflecting a sequential increase of 8 basis points.

Promoter shareholding remained unchanged at 74.99 per cent, while DII ownership stood at 8.93 per cent as of March 2026. The rise in FII ownership indicates continued institutional interest despite the stock's premium valuation.
Also Read - ITC To Bajaj Auto: 5 Major Companies Going Ex-Dividend This Week In May

Abbott India Stock Performance

Abbott India shares have witnessed a correction over the past year. The stock has declined 6.45 per cent in the last one month, 6.63 per cent over the last six months, and 17.23 per cent on a one-year basis.

Despite the recent decline in share price, the company's strong cash generation and shareholder-friendly capital allocation policy continue to support its long-term investment appeal.

About Abbott India

Abbott India Ltd is one of India's leading multinational pharmaceutical companies and is a part of the global healthcare major Abbott. The company markets a wide range of branded generic pharmaceuticals across therapeutic areas such as gastroenterology, women's health, cardiology, diabetes care, vaccines and primary care.

With a strong portfolio of established brands, extensive distribution reach and a long-standing presence in the Indian healthcare market, Abbott India continues to maintain a significant position in the domestic pharmaceutical industry. The company benefits from its parent company's global research capabilities while focusing on the growing demand for healthcare products in India.

What are your thoughts on Abbott India's highest-ever dividend announcement? Share your views in the comments below.
Disclaimer: The article is for informational purposes only and not investment advice.